AstraZeneca and the AI-Powered Drug Design Revolution
AI is accelerating biologic drug discovery by narrowing molecular design space, shortening development cycles, and enabling scientists to target previously 'undruggable' diseases.
AI is accelerating biologic drug discovery by narrowing molecular design space, shortening development cycles, and enabling scientists to target previously 'undruggable' diseases.